Szudy-Szczyrek, A.; Mlak, R.; Mielnik, M.; Mazurek, M.; Chocholska, S.; Podgajna, M.; Szczyrek, M.; Homa-Mlak, I.; Małecka-Massalska, T.; Hus, M.
Circulating Serum MiRNA-8074 as a Novel Prognostic Biomarker for Multiple Myeloma. Cells 2022, 11, 752.
https://doi.org/10.3390/cells11040752
AMA Style
Szudy-Szczyrek A, Mlak R, Mielnik M, Mazurek M, Chocholska S, Podgajna M, Szczyrek M, Homa-Mlak I, Małecka-Massalska T, Hus M.
Circulating Serum MiRNA-8074 as a Novel Prognostic Biomarker for Multiple Myeloma. Cells. 2022; 11(4):752.
https://doi.org/10.3390/cells11040752
Chicago/Turabian Style
Szudy-Szczyrek, Aneta, Radosław Mlak, Michał Mielnik, Marcin Mazurek, Sylwia Chocholska, Martyna Podgajna, Michał Szczyrek, Iwona Homa-Mlak, Teresa Małecka-Massalska, and Marek Hus.
2022. "Circulating Serum MiRNA-8074 as a Novel Prognostic Biomarker for Multiple Myeloma" Cells 11, no. 4: 752.
https://doi.org/10.3390/cells11040752
APA Style
Szudy-Szczyrek, A., Mlak, R., Mielnik, M., Mazurek, M., Chocholska, S., Podgajna, M., Szczyrek, M., Homa-Mlak, I., Małecka-Massalska, T., & Hus, M.
(2022). Circulating Serum MiRNA-8074 as a Novel Prognostic Biomarker for Multiple Myeloma. Cells, 11(4), 752.
https://doi.org/10.3390/cells11040752